Hyundai Bioscience Co., Ltd. (KOSDAQ:048410)

Hyundai Bioscience Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 16, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	544,527	561,851	1,038,982	1,087,244	976,101	1,048,678
Market Cap Growth	-4.04%	-45.92%	-4.44%	11.39%	-6.92%	115.45%
Enterprise Value	515,168	579,143	1,031,571	1,069,527	969,321	1,050,097
Last Close Price	5670.00	7055.00	12295.97	12908.41	11895.53	13756.41
PS Ratio	277.78	37.33	109.58	138.48	105.62	83.82
PB Ratio	4.94	14.25	22.95	18.67	15.85	20.04
P/TBV Ratio	9.37	89.63	73.68	43.38	34.98	81.02
P/FCF Ratio	-	269.15	-	-	-	-
P/OCF Ratio	-	248.93	-	-	-	139.79
EV/Sales Ratio	262.80	38.48	108.80	136.22	104.89	83.93
EV/EBITDA Ratio	-	406.48	-	-	-	-
EV/EBIT Ratio	-	732.19	-	-	-	-
EV/FCF Ratio	-14.55	277.44	-	-	-	-
Debt / Equity Ratio	0.03	0.67	0.12	0.11	0.25	0.71
Debt / EBITDA Ratio	-	18.66	-	-	-	-
Debt / FCF Ratio	-	12.74	-	-	-	-
Asset Turnover	0.02	0.25	0.16	0.11	0.11	0.16
Inventory Turnover	1.44	1.78	1.62	1.63	1.59	1.19
Quick Ratio	5.94	0.14	1.77	2.23	1.73	3.41
Current Ratio	6.40	0.25	2.18	2.67	2.02	4.37
Return on Equity (ROE)	-28.52%	-16.36%	-28.02%	-26.39%	-35.21%	-16.50%
Return on Assets (ROA)	-11.01%	0.82%	-10.20%	-22.24%	-6.66%	-3.51%
Return on Invested Capital (ROIC)	-20.25%	1.56%	-23.13%	-52.30%	-14.85%	-7.12%
Return on Capital Employed (ROCE)	-14.90%	2.00%	-21.40%	-45.10%	-14.70%	-5.30%
Earnings Yield	-4.03%	-1.23%	-1.40%	-1.45%	-2.05%	-0.79%
FCF Yield	-6.50%	0.37%	-0.63%	-1.66%	-0.44%	-1.69%
Buyback Yield / Dilution	-140.29%	-0.10%	-1.04%	-6.64%	-2.79%	-3.67%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.